.
Why C3.ai, Intel, Advanced Micro Devices and Other Artificial Intelligence (AI) Stocks Tumbled Friday
The biggest catalyst driving the market higher over the past year or so has been...
Read MoreWhy C3.ai, Intel, Advanced Micro Devices and Other Artificial Intelligence (AI) Stocks Tumbled Friday
Why Shares of Ali Baba, Jingdong Mall and PDD Holdings Slumped Today
Disappointing export reports have caused the Chinese stock market to fall.
Read MoreWhy Shares of Ali Baba, Jingdong Mall and PDD Holdings Slumped TodayApple's Profitability Once Again Overlooked by Investors, Bank of America Merrill Lynch Says Its Shares Will Have 28% of Upside
In 2018, Wall Street projected Apple's 2023 margins to be around 39%. in fact, the margins were much higher, at 44%.
Read MoreApple's Profitability Once Again Overlooked by Investors, Bank of America Merrill Lynch Says Its Shares Will Have 28% of UpsideAnalysts Set New Chipotle Target Stock Price Ahead of Earnings Release
That's what could happen to Chipotle stock next.
Read MoreAnalysts Set New Chipotle Target Stock Price Ahead of Earnings ReleaseWhat is AbbVie stock doing on Friday?
On Friday, AbbVie Inc (NYSE:ABBV) released an interim analysis of an ongoing 156-week Phase 3 open-label extension study evaluating the long-term safety and tolerability of oral atogipan for the prevention of migraine in patients with chronic or flare-up migraine. According to Benzinga Pro, the company's shares were trading lower with a volume of 3.9 million shares in mid-pan compared to an average volume of 5.6 million shares. Also Read: AbbVie Raises Long-Term Outlook for Immunology Drugs Even as Q4 Revenue Falls
Read MoreWhat is AbbVie stock doing on Friday?BlackRock reported that it managed a record $10.5 trillion in assets as client cash poured in and the market grew.
With the influx of client capital and the market's favorable performance, BlackRock's assets grew by $1.4 trillion in 12 months.
Read MoreBlackRock reported that it managed a record $10.5 trillion in assets as client cash poured in and the market grew.Is Teladoc stock worth buying?
Have Telehealth Providers Entered the Value Arena?
Read MoreIs Teladoc stock worth buying?Think INVISTA's stock is overpriced? One Wall Street analyst thinks maybe not.
Rapid sales and earnings growth make this stock look like a bargain.
Read MoreThink INVISTA's stock is overpriced? One Wall Street analyst thinks maybe not.Why is Coupang stock soaring today?
Shares of Korean e-commerce companies jumped on the price increase.
Read MoreWhy is Coupang stock soaring today?The market dynamics are as follows: April 12
Markets Sink as Large Bank Earnings Disappoint, Inflation Concerns Persist
Read MoreThe market dynamics are as follows: April 12
English 
Chinese